[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100227802":3},{"organization":4,"armGroups":7,"interventions":30,"overallOfficials":51,"centralContacts":42,"locations":55,"responsibleParty":193,"collaborators":42,"id":195,"slug":196,"hasResults":197,"nctId":198,"briefTitle":199,"officialTitle":200,"acronym":42,"eligibilityCriteria":201,"healthyVolunteers":202,"sex":203,"minAge":204,"maxAge":205,"enrollmentInfo":206,"targetDuration":42,"studyType":209,"phases":210,"briefSummary":212,"conditions":213,"keywords":215,"overallStatus":218,"whyStopped":42,"lastUpdateSubmitDate":219,"lastUpdatePostDateStruct":220,"startDateStruct":223,"completionDateStruct":225,"leadSponsor":227,"locationsCount":228},{"fullName":5,"class":6},"Janssen Research & Development, LLC","INDUSTRY",[8,15,20,25],{"label":9,"type":10,"description":11,"interventionNames":12},"Canagliflozin + Phentermine","EXPERIMENTAL","300 mg capsule of Canagliflozin along with 15 mg capsule of Phentermine, taken once daily, orally for 26 weeks.",[13,14],"Drug: Canagliflozin","Drug: Phentermine",{"label":16,"type":10,"description":17,"interventionNames":18},"Canagliflozin + Placebo (Phentermine)","300 mg capsule of Canagliflozin along with matching placebo to Phentermine, taken once daily, orally for 26 weeks.",[13,19],"Drug: Matching Placebo to Phentermine",{"label":21,"type":10,"description":22,"interventionNames":23},"Phentermine + Placebo (Canagliflozin)","15 mg capsule of Phentermine along with matching placebo to Canagliflozin, taken once daily, orally for 26 weeks.",[14,24],"Drug: Matching Placebo to Canagliflozin",{"label":26,"type":27,"description":28,"interventionNames":29},"Placebo","PLACEBO_COMPARATOR","Matching placebo to Canagliflozin and Phentermine, taken once daily, orally for 26 weeks.",[24,19],[31,38,43,47],{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":36},"DRUG","Canagliflozin","300 mg capsule, taken once daily, orally for 26 weeks.",[9,16],[37],"INVOKANA",{"type":32,"name":39,"description":40,"armGroupLabels":41,"otherNames":42},"Phentermine","15 mg capsule, taken once daily, orally for 26 weeks.",[9,21],null,{"type":32,"name":44,"description":45,"armGroupLabels":46,"otherNames":42},"Matching Placebo to Canagliflozin","Placebo capsules look like canagliflozin but do not contain any active drug, taken once daily, orally for 26 weeks.",[21,26],{"type":32,"name":48,"description":49,"armGroupLabels":50,"otherNames":42},"Matching Placebo to Phentermine","Placebo capsules look like phentermine but do not contain any active drug, taken once daily, orally for 26 weeks.",[16,26],[52],{"name":53,"affiliation":5,"role":54},"Janssen Research & Development, LLC Clinical Trial","STUDY_DIRECTOR",[56,67,75,83,91,99,107,114,122,130,138,146,154,162,170,177,185],{"facility":42,"status":42,"city":57,"state":58,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":61,"geoPoint":66,"contacts":42},"Phoenix","Arizona","United States","US",{"type":62,"coordinates":63},"Point",[64,65],-112.07404,33.44838,{"lat":65,"lon":64},{"facility":42,"status":42,"city":68,"state":69,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":70,"geoPoint":74,"contacts":42},"Walnut Creek","California",{"type":62,"coordinates":71},[72,73],-122.06496,37.90631,{"lat":73,"lon":72},{"facility":42,"status":42,"city":76,"state":77,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":78,"geoPoint":82,"contacts":42},"Jacksonville","Florida",{"type":62,"coordinates":79},[80,81],-81.65565,30.33218,{"lat":81,"lon":80},{"facility":42,"status":42,"city":84,"state":85,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":86,"geoPoint":90,"contacts":42},"Meridian","Idaho",{"type":62,"coordinates":87},[88,89],-116.39151,43.61211,{"lat":89,"lon":88},{"facility":42,"status":42,"city":92,"state":93,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":94,"geoPoint":98,"contacts":42},"Evansville","Indiana",{"type":62,"coordinates":95},[96,97],-87.55585,37.97476,{"lat":97,"lon":96},{"facility":42,"status":42,"city":100,"state":101,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":102,"geoPoint":106,"contacts":42},"Lexington","Kentucky",{"type":62,"coordinates":103},[104,105],-84.47772,37.98869,{"lat":105,"lon":104},{"facility":42,"status":42,"city":108,"state":101,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":109,"geoPoint":113,"contacts":42},"Louisville",{"type":62,"coordinates":110},[111,112],-85.75941,38.25424,{"lat":112,"lon":111},{"facility":42,"status":42,"city":115,"state":116,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":117,"geoPoint":121,"contacts":42},"New Orleans","Louisiana",{"type":62,"coordinates":118},[119,120],-90.07507,29.95465,{"lat":120,"lon":119},{"facility":42,"status":42,"city":123,"state":124,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":125,"geoPoint":129,"contacts":42},"Milford","Massachusetts",{"type":62,"coordinates":126},[127,128],-71.51617,42.13982,{"lat":128,"lon":127},{"facility":42,"status":42,"city":131,"state":132,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":133,"geoPoint":137,"contacts":42},"Manlius","New York",{"type":62,"coordinates":134},[135,136],-75.97686,43.00201,{"lat":136,"lon":135},{"facility":42,"status":42,"city":139,"state":140,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":141,"geoPoint":145,"contacts":42},"Warwick","Rhode Island",{"type":62,"coordinates":142},[143,144],-71.41617,41.7001,{"lat":144,"lon":143},{"facility":42,"status":42,"city":147,"state":148,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":149,"geoPoint":153,"contacts":42},"Mt. Pleasant","South Carolina",{"type":62,"coordinates":150},[151,152],-79.86259,32.79407,{"lat":152,"lon":151},{"facility":42,"status":42,"city":155,"state":156,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":157,"geoPoint":161,"contacts":42},"Nashville","Tennessee",{"type":62,"coordinates":158},[159,160],-86.78444,36.16589,{"lat":160,"lon":159},{"facility":42,"status":42,"city":163,"state":164,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":165,"geoPoint":169,"contacts":42},"Dallas","Texas",{"type":62,"coordinates":166},[167,168],-96.80667,32.78306,{"lat":168,"lon":167},{"facility":42,"status":42,"city":171,"state":164,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":172,"geoPoint":176,"contacts":42},"Odessa",{"type":62,"coordinates":173},[174,175],-102.36764,31.84568,{"lat":175,"lon":174},{"facility":42,"status":42,"city":178,"state":179,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":180,"geoPoint":184,"contacts":42},"Norfolk","Virginia",{"type":62,"coordinates":181},[182,183],-76.28522,36.84681,{"lat":183,"lon":182},{"facility":42,"status":42,"city":186,"state":187,"zip":42,"country":59,"countryCode":60,"cosmosGeoPoint":188,"geoPoint":192,"contacts":42},"Wauwatosa","Wisconsin",{"type":62,"coordinates":189},[190,191],-88.00759,43.04946,{"lat":191,"lon":190},{"type":194,"investigatorFullName":42,"investigatorTitle":42,"investigatorAffiliation":42,"oldNameTitle":42,"oldOrganization":42},"SPONSOR","100227802","phase-2-effects-of-co-administration-of-canagliflozin-300-mg-and-phentermine-15-mg-with-placebo-in-the-treatment-of-non-diabetic-overweight-and-obese-participants-100227802",true,"NCT02243202","Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants","A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects","Inclusion Criteria:\n\n* Must have BMI \\>=30 kg\u002Fm2 and \\\u003C50 kg\u002Fm2 at screening or BMI \\>=27 kg\u002Fm2 and \\\u003C50 kg\u002Fm2 at screening in the presence of a comorbidity of hypertension and\u002For dyslipidemia\n* Must have stable weight, ie, change of \\\u003C =5% in the 3 months before screening\n* Must agree to utilize a highly effective method of birth control\n\nExclusion Criteria:\n\n* An established diagnosis of diabetes mellitus\n* Has a history of obesity with a known secondary cause (eg, Cushing's disease\u002Fsyndrome)\n* Has a history of hereditary glucose-galactose malabsorption or primary renal glycosuria\n* Myocardial infarction, unstable angina, revascularization procedure, or cerebrovascular accident within 12 weeks before screening\n* Has an Glycated hemoglobin (HBA1c) greater than or equal (\\>=) to 65 percent\n* An average of 3 seated blood pressure (BP) readings of systolic BP \\>= 160 mm Hg and\u002For Diastolic BP \\>= 100 millimeters of mercury at screening",false,"ALL","18 Years","65 Years",{"count":207,"type":208},335,"ACTUAL","INTERVENTIONAL",[211],"PHASE2","The purpose of this study is to compare the effects of canagliflozin and phentermine to those of placebo to promote on a change in body weight over a 26 week period.",[214],"Obesity",[214,216,33,39,217],"Overweight","INVOKANA®","COMPLETED","2016-08-10",{"date":221,"type":222},"2016-10-06","ESTIMATED",{"date":224,"type":42},"2014-09",{"date":226,"type":208},"2015-06",{"name":5,"class":6},17]